2022年11月22日

| FMI全球基于ai的临床试验解决方案提供商市场预计在2022年价值17亿美元和142亿美元,到2032年,增长23.2%的复合年增长率的预测期期间2022 - 2032。未来的市场洞察力、市场研究和竞争情报提供者,分析基于AI的临床试验解决方案提供商市场将见证稳定增长由于增加政府和私营部门改进医疗保健设施的举措通过新颖的人工智能技术的实现和药物。人工智能(AI)和机器学习技术正逐渐加强临床试验效率,简化临床实践过程,并允许制药公司发现小说更快和更有效的治疗和疗法。请求示例报告@ https://www.futuremarketinsights.com/reports/sample/rep - gb - 14947 AiCure LLC国际机业务公司(IBM)北美地区主导全球基于AI的临床试验解决方案提供商的市场份额由于地区扩大政府和企业的投资基于AI技术来实现更高的效率和改进业务流程和增加使用先进的技术,如人工智能(AI),机器学习(ML),和深度学习在临床试验中。欧洲拥有第二大基于ai的临床试验解决方案提供商市场最大份额东盟地区紧随其后。基于ai的高级治疗应用的临床试验是肿瘤学与Mn 2022年432.7美元的市场规模。越来越强调集成人工智能在癌症治疗改善癌症诊断的速度和准确性是驱动因素。关键外卖市场研究基于ai的临床试验解决方案提供商市场预计到2032年将增加8倍价值市场的可观的增长率预计将增长24.5%,价值142亿美元的2032 AiCure LLC忘却。AI, Inc .和Saama技术公司是基于AI的顶级巨头临床试验解决方案提供商基于最终用途,制药公司占大约65%的全球市场份额2021年Saama技术公司宣布了一项与甲骨文公司合作在2021年3月将甲骨文的健康科学的临床与Saama智能应用程序的一个平台。“提高意识的优势基于ai的临床试验和措施来支持公共和私营部门在不同治疗领域的研发推动基于ai临床试验解决方案提供商”的需要,未来市场见解分析师说。 Winning Strategy To fulfil the rising demand, major firms are focusing on initiatives such as mergers and acquisitions and the expansion of worldwide distribution networks. To stay competitive in the post-coronavirus economy, companies are launching innovative products into the market. Speak to our Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-14947 More Valuable Insights Available Future Market Insights, in its new offering, presents an unbiased analysis of the global AI-based Clinical Trials Solution Provider market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032. The study reveals essential insights by Application in Clinical Trial Phases (Clinical Trial Design, Patient Enrichment and enrolment, Investigator and site selection, Patient Monitoring, Medication Adherence, Patient Retention, Data Analytics), by Trial phase (Phase I, II and III), by Therapeutic Applications (Oncology, Cardiovascular, Neurological, Infectious, and Metabolic diseases) and across key regions (North America, Latin America, Europe, East Asia, South Asia & Oceania, and the Middle East & Africa). Key Segments Covered in AI-based Clinical Trials Solution Provider Industry Survey AI-based Clinical Trials Solution Provider Market by Therapeutic Applications: Cardiovascular diseases Phase I Pharmaceutical companies North America